EMEA-001159-PIP02-12 - paediatric investigation plan

misoprostol
PIPHuman

Key facts

Active substance
misoprostol
Therapeutic area
Other
Decision number
P/0163/2012
PIP number
EMEA-001159-PIP02-12
Pharmaceutical form(s)
Vaginal delivery system
Condition(s) / indication(s)
Induction of labour
Route(s) of administration
Vaginal use
Contact for public enquiries

Ferring pharmaceuticals A/S

gb3-info@ferring.com 
United Kingdom
+44 1355293166
+44 1355269661

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Decision date
Compliance check done
Yes
Compliance procedure number
EMEA-C-001159-PIP02-12
Compliance opinion date
Compliance outcome
Positive

Decision

Share this page